PSA test cuts deaths from prostate cancer, study finds

06/30/2010 | Bloomberg

A 14-year Swedish study showed that a prostate-specific antigen blood test reduced mortality from prostate cancer by nearly 50%. Researchers found that 44 of 10,000 men who were screened for prostate cancer every two years died of the disease compared with 78 of 10,000 who hadn't undergone screening.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Health Services Researcher
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO